Loading...
XNAS
IINN
Market cap26mUSD
Dec 05, Last price  
1.11USD
1D
0.00%
1Q
-8.26%
IPO
-76.63%
Name

Inspira Technologies Oxy BHN Ltd

Chart & Performance

D1W1MN
XNAS:IINN chart
P/E
P/S
EPS
Div Yield, %
Shrs. gr., 5y
6.51%
Rev. gr., 5y
%
Revenues
0k
0000-4,678,00000
Net income
-11k
L-99.90%
-39,600-4,584,000-7,233,000-16,961,000-4,002,000-11,286,000-11,053
CFO
-9m
L-3.92%
4,800-1,111,000-1,876,000-7,877,000-7,380,000-9,756,000-9,374,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Inspira Technologies Oxy B.H.N. Ltd., a specialty medical device company, engages in the research, development, manufacture, and marketing of respiratory support technology to provide an alternative to invasive mechanical ventilation (MV) for the treatment of respiratory failure. Its lead product is the augmented respiration technology system (ART), a respiratory support system comprising minimally invasive, portable dual lumen cannula, which is inserted into the jugular vein and utilizes extra-corporeal direct blood oxygenation to elevate and stabilize declining oxygen saturation levels. The company was formerly known as Insense Medical Ltd. and changed its name to Inspira Technologies Oxy B.H.N. Ltd. in July 2020. The company was incorporated in 2018 and is based in Ra'annana, Israel.
IPO date
Jul 13, 2021
Employees
32
Domiciled in
IL
Incorporated in
IL

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT